SL Science Holding Limited

Contributing Author

Recent Articles by SL Science Holding Limited

Aug-11	SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma SLBT -5.65% GlobeNewswire
Jul-17	SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology SLBT GlobeNewswire
Jul-10	SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma SLBT GlobeNewswire
Jun-18	SL Science Holding Limited Reports Full Year 2025 Financial Results SLBT -9.25% SLBT -21.93% GlobeNewswire